Policy for addressing environmental, social and sustainability matters through corporate governance
First written in FY2020. 5 of 7 entries say "Advanced", first in FY2022. Latest entry: FY2026.
The whole theme swung hardest in 2021: 1 of 8 companies on the "Worse" side.
11 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「In April 2023, we established the Sustainability Committee, chaired by the Representative Director, President and CEO. In cooperation with relevant departments and Group companies, the Committee formulates policies for sustainability-related activities, sets priority activity themes and KPIs for CSV and ESG, and promotes activities across the Group.」
Continued KPI management by the Sustainability Committee and disclosed fiscal 2025 results, including an 11% increase in disposable product sales volume, a 22% increase in sales of automated blood processing systems, and a 13.2% proportion of women in management positions. - FY2025AdvancedAnnual report
「CO2 emissions (versus fiscal 2018, Scope 1+2): reduction rate of 50.4% (fiscal 2030); reduction rate of 100% (fiscal 2040); 26.8% reduction (Note 2)」
Managed CSV and ESG through the Sustainability Committee and disclosed fiscal 2024 results, including a 26.8% reduction in Scope 1+2 emissions, a 37.5% renewable energy utilization rate, a 38.5% reduction in water usage, and an 89.3% recycling rate. - FY2024AdvancedAnnual report
「In April 2023, we established the Sustainability Committee, chaired by the Representative Director, President and CEO. In cooperation with relevant departments and Group companies, the Committee formulates policies for sustainability-related activities, sets priority activity themes and KPIs for CSV and ESG, and promotes activities across the Group.」
Continued KPI setting, monitoring, and reporting to the Board of Directors by the Sustainability Committee, and disclosed CSV/ESG results. Examples included a 73% radial approach rate in coronary procedures, approximately 9,200 patients using medical care services, and a 12% year-on-year increase in sales of automated blood processing systems. - FY2023AdvancedAnnual report
「In April 2023, we established the Sustainability Committee, chaired by the Representative Director, President and CEO. In cooperation with relevant departments and Group companies, the Committee formulates policies for sustainability-related activities, sets priority activity themes and KPIs for CSV and ESG, and promotes activities across the Group.」
Gave concrete form to the sustainability policy centered on CSV and ESG through the Sustainability Committee established in April 2023, KPI monitoring, regular reporting to the Board of Directors, and linkage to executive compensation. - FY2022AdvancedAnnual report
「We are committed not only to financial targets but also to sustainability management. We have established 2 categories: CSV (creating value for society), realized through our business activities, and ESG (environmental, social, and governance), which supports CSV. Under CSV, we set specific themes for each company in 3 priority areas: expanding access to medical technologies and services and improving access to healthcare; providing healthcare that supports each individual’s life; and co-creating sustainable healthcare systems. For ESG, we identified priority themes for each of the environmental, social, and governance areas and set specific quantitative targets.」
Systematized the existing sustainability policy into 2 categories, CSV and ESG, 3 priority areas under CSV, and quantitative targets under ESG. - FY2021RestatedAnnual report
「Important matters closely related to corporate governance, including the development of systems in the environmental and social fields and initiatives for sustainability.」
The Company continues to expressly state its policy of making environmental, social, and sustainability matters subject to deliberation by the Corporate Governance Committee. - FY2020First statedAnnual report
「Important matters closely related to corporate governance, including the development of systems in the environmental and social fields and initiatives for sustainability.」
The Company expressly identified initiatives in the environmental and social fields and sustainability as matters for deliberation by the Corporate Governance Committee. In addition to the previous references to the corporate philosophy and social responsibility, these matters were identified for the first time as areas of responsibility within the governance structure.